Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;15(2):157-168.
doi: 10.1016/j.chmed.2022.06.014. Epub 2023 Mar 8.

New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches

Affiliations
Review

New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches

Kexin Jia et al. Chin Herb Med. 2023 Apr.

Abstract

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high pathogenicity and infectiousness has become a sudden and lethal pandemic worldwide. Currently, there is no accepted specific drug for COVID-19 treatment. Therefore, it is extremely urgent to clarify the pathogenic mechanism and develop effective therapies for patients with COVID-19. According to several reliable reports from China, traditional Chinese medicine (TCM), especially for three Chinese patent medicines and three Chinese medicine formulas, has been demonstrated to effectively alleviate the symptoms of COVID-19 either used alone or in combination with Western medicines. In this review, we systematically summarized and analyzed the pathogenesis of COVID-19, the detailed clinical practice, active ingredients investigation, network pharmacology prediction and underlying mechanism verification of three Chinese patent medicines and three Chinese medicine formulas in the COVID-19 combat. Additionally, we summarized some promising and high-frequency drugs of these prescriptions and discussed their regulatory mechanism, which provides guidance for the development of new drugs against COVID-19. Collectively, by addressing critical challenges, for example, unclear targets and complicated active ingredients of these medicines and formulas, we believe that TCM will represent promising and efficient strategies for curing COVID-19 and related pandemics.

Keywords: COVID-19; Huashi Baidu Formula; Jinhua Qinggan Granules; Lianhua Qingwen Capsule; Qingfei Paidu Decoction; SARS-CoV-2; Xuanfei Baidu Formula; Xuebijing Injection; traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Protective role of three Chinese patent medicines and three Chinese medicine formulas in COVID-19. JHQG: Jinhua Qinggan Granule; LHQW: Lianhua Qingwen Granule; QFPD: Qingfei Paidu Granule; XFBD: Xuanfei Baidu Granule; XBJ: Xuebijing Injection.

Similar articles

Cited by

References

    1. An X., Xu X., Xiao M., Min X., Lyu Y., Tian J.…Tong X. Efficacy of Jinhua Qinggan Granules combined with western medicine in the treatment of confirmed and suspected COVID-19: A randomized controlled trial. Frontiers in Medicine (Lausanne) 2021;8 - PMC - PubMed
    1. Báez-Santos Y.M., Barraza S.J., Wilson M.W., Agius M.P., Mielech A.M., Davis N.M.…Mesecar A.D. X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases. Journal of Medical Chemistry. 2014;57(6):2393–2412. - PMC - PubMed
    1. Báez-Santos Y.M., St John S.E., Mesecar A.D. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antiviral Research. 2015;115:21–38. - PMC - PubMed
    1. Cao L., Li Z., Ren Y., Wang M., Yang Z., Zhang W.…Nie S. Xuebijing protects against septic acute liver injury based on regulation of GSK-3β pathway. Frontiers in Pharmacology. 2021;12 - PMC - PubMed
    1. Chen H., Song Y.P., Gao K., Zhao L.T., Ma L. Efficacy and safety of Jinhua Qinggan Granules for coronavirus disease 2019 (COVID-19): A protocol of a systematic review and Meta-analysis. Medicine (Baltimore) 2020;99(24):e20612. - PMC - PubMed

LinkOut - more resources